
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (17): 2147-2154.DOI: 10.12114/j.issn.1007-9572.2022.0568
Special Issue: 肿瘤最新文章合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:2022-06-15
Revised:2022-10-12
Published:2023-06-15
Online:2022-10-31
Contact:
ZHOU Fenghai
通讯作者:
周逢海
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0568
| 步骤 | 检索词 |
|---|---|
| #1 | ( "Prostatectomy" [Title/Abstract] OR "Prostatectomies" [Title/Abstract] OR "suprapubic prostatectomies" [Title/Abstract] OR "suprapubic prostatectomy " [Title/Abstract] OR "retropubic prostatectomies" [Title/Abstract] OR "retropubic prostatectomy" [Title/Abstract] OR "radical prostatectomy" [Title/Abstract] OR(( "radical" [All Fields] OR "radical's" [All Fields] OR "radicals" [All Fields]) AND( "resect" [All Fields] OR "resectability" [All Fields] OR "resectable" [All Fields] OR "resectates" [All Fields] OR "resected" [All Fields] OR "resecting" [All Fields] OR "Resection" [All Fields] OR "resectional" [All Fields] OR "resectioned" [All Fields] OR "resectioning" [All Fields] OR "resections" [All Fields] OR "resective" [All Fields] OR "resects" [All Fields]) AND " prostate cancer" [Title/Abstract])) |
| #2 | ( "positive margin" [Title/Abstract] OR "positive excision margins" [Title/Abstract] OR "margins of excision" [Title/Abstract] OR "excision margin" [Title/Abstract] OR "excision margins" [Title/Abstract] OR "resection margin" [Title/Abstract] OR "resection margins" [Title/Abstract] OR "surgical margins" [Title/Abstract] OR "surgical margin" [Title/Abstract] OR "positive surgical margins" [Title/Abstract] OR "positive surgical margin" [Title/Abstract] OR "negative surgical margins" [Title/Abstract] OR "negative surgical margin" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margin" [Title/Abstract]) |
| #3 | ( "Risk factors" [Title/Abstract] OR "social risk factors" [Title/Abstract] OR "social risk factor" [Title/Abstract] OR "health correlates" [Title/Abstract] OR "population at risk" [Title/Abstract] OR "populations at risk" [Title/Abstract] OR "risk scores" [Title/Abstract] OR "risk score" [Title/Abstract] OR "risk factor scores" [Title/Abstract] OR "risk factor score" [Title/Abstract] OR "dangerous factor" [Title/Abstract] OR "hazardous factors" [Title/Abstract] OR "risky factors" [Title/Abstract] OR "risks factors" [Title/Abstract] OR "Risk-factors" [Title/Abstract] OR "danger factors" [Title/Abstract] OR "danger factor" [Title/Abstract] OR "hazard factors" [Title/Abstract] OR "Factor" [Title/Abstract] OR "Factors" [Title/Abstract] OR " elements" [Title/Abstract] OR "element" [Title/Abstract]) |
| #4 | #1 AND #2 AND #3 |
Table 1 Strategy for searching studies
| 步骤 | 检索词 |
|---|---|
| #1 | ( "Prostatectomy" [Title/Abstract] OR "Prostatectomies" [Title/Abstract] OR "suprapubic prostatectomies" [Title/Abstract] OR "suprapubic prostatectomy " [Title/Abstract] OR "retropubic prostatectomies" [Title/Abstract] OR "retropubic prostatectomy" [Title/Abstract] OR "radical prostatectomy" [Title/Abstract] OR(( "radical" [All Fields] OR "radical's" [All Fields] OR "radicals" [All Fields]) AND( "resect" [All Fields] OR "resectability" [All Fields] OR "resectable" [All Fields] OR "resectates" [All Fields] OR "resected" [All Fields] OR "resecting" [All Fields] OR "Resection" [All Fields] OR "resectional" [All Fields] OR "resectioned" [All Fields] OR "resectioning" [All Fields] OR "resections" [All Fields] OR "resective" [All Fields] OR "resects" [All Fields]) AND " prostate cancer" [Title/Abstract])) |
| #2 | ( "positive margin" [Title/Abstract] OR "positive excision margins" [Title/Abstract] OR "margins of excision" [Title/Abstract] OR "excision margin" [Title/Abstract] OR "excision margins" [Title/Abstract] OR "resection margin" [Title/Abstract] OR "resection margins" [Title/Abstract] OR "surgical margins" [Title/Abstract] OR "surgical margin" [Title/Abstract] OR "positive surgical margins" [Title/Abstract] OR "positive surgical margin" [Title/Abstract] OR "negative surgical margins" [Title/Abstract] OR "negative surgical margin" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margin" [Title/Abstract]) |
| #3 | ( "Risk factors" [Title/Abstract] OR "social risk factors" [Title/Abstract] OR "social risk factor" [Title/Abstract] OR "health correlates" [Title/Abstract] OR "population at risk" [Title/Abstract] OR "populations at risk" [Title/Abstract] OR "risk scores" [Title/Abstract] OR "risk score" [Title/Abstract] OR "risk factor scores" [Title/Abstract] OR "risk factor score" [Title/Abstract] OR "dangerous factor" [Title/Abstract] OR "hazardous factors" [Title/Abstract] OR "risky factors" [Title/Abstract] OR "risks factors" [Title/Abstract] OR "Risk-factors" [Title/Abstract] OR "danger factors" [Title/Abstract] OR "danger factor" [Title/Abstract] OR "hazard factors" [Title/Abstract] OR "Factor" [Title/Abstract] OR "Factors" [Title/Abstract] OR " elements" [Title/Abstract] OR "element" [Title/Abstract]) |
| #4 | #1 AND #2 AND #3 |
| 第一作者 | 发表年份(年) | 研究地区 | 样本量(例) | 手术方式 | 结局指标 | NOS评分(分) | |
|---|---|---|---|---|---|---|---|
| 病例组 | 对照组 | ||||||
| 张靖博[ | 2021 | 河南 | 64 | 188 | LRP | ①②⑦⑧ | 8 |
| 张平新[ | 2020 | 新疆 | 26 | 73 | LRP | ⑧ | 6 |
| 阎乙夫[ | 2011 | 北京 | 76 | 112 | LRP | ⑦⑧ | 8 |
| 陈星[ | 2021 | 福建 | 36 | 86 | LRP | ①③④⑦⑧ | 7 |
| 张争[ | 2019 | 北京 | 57 | 120 | LRP | ⑧ | 7 |
| 吴丹[ | 2020 | 江苏 | 34 | 82 | LRP | ⑧ | 6 |
| 缪志俊[ | 2021 | 江苏 | 79 | 420 | LRP | ①③⑤ | 7 |
| 王硕[ | 2021 | 北京 | 97 | 83 | — | ⑦⑧ | 8 |
| 侯惠民[ | 2018 | 北京 | 94 | 226 | — | ② | 7 |
| 范效铮[ | 2021 | 陕西 | 158 | 360 | RARP | ①⑤ | 8 |
| 屈武功[ | 2021 | 河南 | 106 | 204 | RARP | ② | 7 |
| 张春雷[ | 2018 | 上海 | 47 | 143 | RARP | ①⑧ | 7 |
| 沈诞[ | 2012 | 上海 | 258 | 1 390 | RARP | ⑤ | 7 |
| 瞿旻[ | 2017 | 上海 | 151 | 249 | RARP | ①⑤ | 8 |
| 韩涛[ | 2013 | 江苏 | 98 | 162 | LRP | ④⑥ | 6 |
| 张铁龙[ | 2015 | 上海 | 61 | 184 | ORP | ①⑦ | 6 |
| 丁攀[ | 2019 | 江西 | 118 | 114 | — | ①②④⑥ | 7 |
| 洪锴[ | 2008 | 北京 | 9 | 24 | LRP | ⑤⑦ | 7 |
| YANG[ | 2017 | 江苏 | 86 | 210 | LRP | ③④⑥ | 7 |
| WANG[ | 2021 | 北京 | 106 | 94 | — | ④⑤ | 8 |
| ZHOU[ | 2021 | 天津 | 267 | 230 | — | ①⑦ | 8 |
Table 2 Table of basic characteristics and risk of bias in included studies
| 第一作者 | 发表年份(年) | 研究地区 | 样本量(例) | 手术方式 | 结局指标 | NOS评分(分) | |
|---|---|---|---|---|---|---|---|
| 病例组 | 对照组 | ||||||
| 张靖博[ | 2021 | 河南 | 64 | 188 | LRP | ①②⑦⑧ | 8 |
| 张平新[ | 2020 | 新疆 | 26 | 73 | LRP | ⑧ | 6 |
| 阎乙夫[ | 2011 | 北京 | 76 | 112 | LRP | ⑦⑧ | 8 |
| 陈星[ | 2021 | 福建 | 36 | 86 | LRP | ①③④⑦⑧ | 7 |
| 张争[ | 2019 | 北京 | 57 | 120 | LRP | ⑧ | 7 |
| 吴丹[ | 2020 | 江苏 | 34 | 82 | LRP | ⑧ | 6 |
| 缪志俊[ | 2021 | 江苏 | 79 | 420 | LRP | ①③⑤ | 7 |
| 王硕[ | 2021 | 北京 | 97 | 83 | — | ⑦⑧ | 8 |
| 侯惠民[ | 2018 | 北京 | 94 | 226 | — | ② | 7 |
| 范效铮[ | 2021 | 陕西 | 158 | 360 | RARP | ①⑤ | 8 |
| 屈武功[ | 2021 | 河南 | 106 | 204 | RARP | ② | 7 |
| 张春雷[ | 2018 | 上海 | 47 | 143 | RARP | ①⑧ | 7 |
| 沈诞[ | 2012 | 上海 | 258 | 1 390 | RARP | ⑤ | 7 |
| 瞿旻[ | 2017 | 上海 | 151 | 249 | RARP | ①⑤ | 8 |
| 韩涛[ | 2013 | 江苏 | 98 | 162 | LRP | ④⑥ | 6 |
| 张铁龙[ | 2015 | 上海 | 61 | 184 | ORP | ①⑦ | 6 |
| 丁攀[ | 2019 | 江西 | 118 | 114 | — | ①②④⑥ | 7 |
| 洪锴[ | 2008 | 北京 | 9 | 24 | LRP | ⑤⑦ | 7 |
| YANG[ | 2017 | 江苏 | 86 | 210 | LRP | ③④⑥ | 7 |
| WANG[ | 2021 | 北京 | 106 | 94 | — | ④⑤ | 8 |
| ZHOU[ | 2021 | 天津 | 267 | 230 | — | ①⑦ | 8 |
| 危险因素 | 纳入研究数(篇) | 异质性分析结果 | 效应模型 | Meta分析结果 | ||
|---|---|---|---|---|---|---|
| I2值(%) | P值 | OR(95%CI) | P值 | |||
| LRP | ||||||
| 术前PSA | 3[ | 87.7 | <0.001 | 随机效应模型 | 1.47(0.42,5.09) | 0.548 |
| 穿刺阳性针数 | 3[ | 84.3 | 0.002 | 随机效应模型 | 2.17(0.98,4.80) | 0.057 |
| 术前临床T分期 | 2[ | 43.9 | 0.182 | 固定效应模型 | 4.57(2.57,8.12) | <0.001 |
| 术后病理T分期 | 6[ | 79.2 | <0.001 | 随机效应模型 | 4.80(2.20,10.48) | <0.001 |
| 术后Gleason评分 | 3[ | 0 | 0.739 | 固定效应模型 | 2.46(1.57,3.86) | <0.001 |
| RARP | ||||||
| 术前PSA | 3[ | 22.4 | 0.275 | 固定效应模型 | 2.17(1.60,2.94) | <0.001 |
| 术前临床T分期 | 3[ | 81.6 | 0.004 | 随机效应模型 | 1.19(0.52,2.74) | 0.678 |
Table 3 Subgroup analysis of different risk factors for PSMs after radical prostatectomy
| 危险因素 | 纳入研究数(篇) | 异质性分析结果 | 效应模型 | Meta分析结果 | ||
|---|---|---|---|---|---|---|
| I2值(%) | P值 | OR(95%CI) | P值 | |||
| LRP | ||||||
| 术前PSA | 3[ | 87.7 | <0.001 | 随机效应模型 | 1.47(0.42,5.09) | 0.548 |
| 穿刺阳性针数 | 3[ | 84.3 | 0.002 | 随机效应模型 | 2.17(0.98,4.80) | 0.057 |
| 术前临床T分期 | 2[ | 43.9 | 0.182 | 固定效应模型 | 4.57(2.57,8.12) | <0.001 |
| 术后病理T分期 | 6[ | 79.2 | <0.001 | 随机效应模型 | 4.80(2.20,10.48) | <0.001 |
| 术后Gleason评分 | 3[ | 0 | 0.739 | 固定效应模型 | 2.46(1.57,3.86) | <0.001 |
| RARP | ||||||
| 术前PSA | 3[ | 22.4 | 0.275 | 固定效应模型 | 2.17(1.60,2.94) | <0.001 |
| 术前临床T分期 | 3[ | 81.6 | 0.004 | 随机效应模型 | 1.19(0.52,2.74) | 0.678 |
| 危险因素 | 随机效应模型 | 固定效应模型 | ||
|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 术前PSA | 1.77(1.18,2.65) | 0.006 | 1.05(1.02,1.08) | <0.001 |
| 穿刺阳性针数百分比 | 1.83(1.35,2.47) | <0.001 | 1.83(1.35,2.47) | <0.001 |
| 穿刺阳性针数 | 2.17(0.98,4.80) | 0.057 | 1.24(1.14,1.34) | <0.001 |
| 穿刺Gleason评分 | 2.25(1.63,3.10) | <0.001 | 2.14(1.67,2.74) | <0.001 |
| 穿刺神经周围侵犯 | 5.83(2.05,16.59) | 0.001 | 6.09(4.04,9.17) | <0.001 |
| 术前临床T分期 | 2.17(1.06,4.42) | 0.033 | 2.08(1.58,2.74) | <0.001 |
| 术后病理T分期 | 4.30(2.43,7.63) | <0.001 | 2.98(2.28,3.88) | <0.001 |
| 术后Gleason评分 | 2.55(1.75,3.72) | <0.001 | 2.33(1.80,3.01) | <0.001 |
Table 4 Sensitivity analysis of risk factors for PSMs after radical prostatectomy in Chinese men
| 危险因素 | 随机效应模型 | 固定效应模型 | ||
|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 术前PSA | 1.77(1.18,2.65) | 0.006 | 1.05(1.02,1.08) | <0.001 |
| 穿刺阳性针数百分比 | 1.83(1.35,2.47) | <0.001 | 1.83(1.35,2.47) | <0.001 |
| 穿刺阳性针数 | 2.17(0.98,4.80) | 0.057 | 1.24(1.14,1.34) | <0.001 |
| 穿刺Gleason评分 | 2.25(1.63,3.10) | <0.001 | 2.14(1.67,2.74) | <0.001 |
| 穿刺神经周围侵犯 | 5.83(2.05,16.59) | 0.001 | 6.09(4.04,9.17) | <0.001 |
| 术前临床T分期 | 2.17(1.06,4.42) | 0.033 | 2.08(1.58,2.74) | <0.001 |
| 术后病理T分期 | 4.30(2.43,7.63) | <0.001 | 2.98(2.28,3.88) | <0.001 |
| 术后Gleason评分 | 2.55(1.75,3.72) | <0.001 | 2.33(1.80,3.01) | <0.001 |
| 危险因素 | 排除文献 | 排除前 | 排除后 | ||||
|---|---|---|---|---|---|---|---|
| 模型 | OR(95%CI) | P值 | 模型 | OR(95%CI) | P值 | ||
| 术前PSA | [ | 随机效应模型 | 1.77(1.18,2.65) | 0.006 | 固定效应模型 | 2.31(1.88,2.83) | <0.001 |
| 穿刺阳性针数 | [ | 随机效应模型 | 2.17(0.98,4.80) | 0.057 | 固定效应模型 | 3.09(1.81,5.26) | <0.001 |
| 穿刺神经周围侵犯 | [ | 随机效应模型 | 5.83(2.05,16.59) | 0.001 | 固定效应模型 | 3.79(2.30,6.24) | <0.001 |
| 术前临床T分期 | [ | 随机效应模型 | 2.17(1.06,4.42) | 0.033 | 固定效应模型 | 1.95(1.41,2.71) | <0.001 |
| 术后病理T分期 | [ | 随机效应模型 | 4.30(2.43,7.63) | <0.001 | 固定效应模型 | 3.77(2.58,5.51) | <0.001 |
Table 5 Exclusion analysis of risk factors for PSMs after radical prostatectomy in Chinese men
| 危险因素 | 排除文献 | 排除前 | 排除后 | ||||
|---|---|---|---|---|---|---|---|
| 模型 | OR(95%CI) | P值 | 模型 | OR(95%CI) | P值 | ||
| 术前PSA | [ | 随机效应模型 | 1.77(1.18,2.65) | 0.006 | 固定效应模型 | 2.31(1.88,2.83) | <0.001 |
| 穿刺阳性针数 | [ | 随机效应模型 | 2.17(0.98,4.80) | 0.057 | 固定效应模型 | 3.09(1.81,5.26) | <0.001 |
| 穿刺神经周围侵犯 | [ | 随机效应模型 | 5.83(2.05,16.59) | 0.001 | 固定效应模型 | 3.79(2.30,6.24) | <0.001 |
| 术前临床T分期 | [ | 随机效应模型 | 2.17(1.06,4.42) | 0.033 | 固定效应模型 | 1.95(1.41,2.71) | <0.001 |
| 术后病理T分期 | [ | 随机效应模型 | 4.30(2.43,7.63) | <0.001 | 固定效应模型 | 3.77(2.58,5.51) | <0.001 |
Figure 11 The funnel plot assessing potential publication bias for the meta-analysis of the impact of pre-radical prostatectomy clinical T stage on PSMs
Figure 12 The funnel plot assessing potential publication bias for the meta-analysis of the impact of post-radical prostatectomy pathological T stage on PSMs
Figure 13 The funnel plot assessing potential publication bias for the meta-analysis of the impact of post-radical prostatectomy Gleason score on PSMs
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
张靖博. 腹膜外途径腹腔镜下根治性前列腺切除术切缘阳性的影响因素分析[J]. 中国现代医药杂志,2021,23(3):33-36. DOI:10.3969/j.issn.1672-9463.2021.03.008.
|
| [6] |
张平新,王文光,马军,等. 腹膜外途径腹腔镜下根治性前列腺切除术切缘阳性的影响因素[J]. 现代泌尿外科杂志,2020,25(3):247-251.
|
| [7] |
阎乙夫,黄毅,马潞林. 腹腔镜根治性前列腺切除术后切缘阳性的相关因素分析[J]. 临床泌尿外科杂志,2011,26(12):901-905. DOI:10.3969/j.issn.1001-1420.2011.12.006.
|
| [8] |
陈星,李炤,何裕杰. 腹腔镜前列腺癌根治术后切缘阳性的影响因素及对患者术后生化复发的影响[J]. 医学理论与实践,2021,34(21):3742-3744. DOI:10.19381/j.issn.1001-7585.2021.21.023.
|
| [9] |
张争,张克楠,洪保安,等. 腹腔镜前列腺癌根治术后切缘阳性的相关影响因素分析[J]. 中国肿瘤临床,2019,46(6):299-302. DOI:10.3969/j.issn.1000-8179.2019.06.276.
|
| [10] |
吴丹. 腹腔镜前列腺癌根治术围手术期指标影响因素分析[D]. 苏州:苏州大学,2020.
|
| [11] |
缪志俊,李鹏,徐宏博,等. 腹腔镜下前列腺癌根治术后切缘阳性的危险因素分析[J]. 现代泌尿生殖肿瘤杂志,2021,13(5):274-277.
|
| [12] |
王硕,杜鹏,曹煜东,等. 根治性前列腺切除术后前列腺尖端、基底切缘阳性的危险因素分析[J]. 中华泌尿外科杂志,2021,42(4):283-288. DOI:10.3760/cma.j.cn112330-20210106-00008.
|
| [13] |
侯惠民,江炘,刘明,等. 根治性前列腺切除术后切缘阳性的临床特征和影响因素分析[J]. 中华泌尿外科杂志,2018,39(10):740-744. DOI:10.3760/cma.j.issn.1000-6702.2018.10.004.
|
| [14] |
范效铮,权鹏鹤,张龙龙,等. 机器人辅助腹腔镜根治性前列腺切除术患者特征及切缘阳性分析[J]. 微创泌尿外科杂志,2021,10(2):105-110. DOI:10.19558/j.cnki.10-1020/r.2021.02.007.
|
| [15] |
屈武功,董彪,陶金,等. 机器人辅助腹腔镜根治性前列腺切除术后切缘阳性的影响因素分析[J]. 中华泌尿外科杂志,2021,42(4):289-293. DOI:10.3760/cma.j.cn112330-20200430-00338.
|
| [16] |
张春雷,陈锐,孔德沛,等. 机器人辅助腹腔镜根治性前列腺切除术后切缘阳性和生化复发的影响因素及相关性分析[J]. 中华泌尿外科杂志,2018,39(12):905-910. DOI:10.3760/cma.j.issn.1000-6702.2018.12.006.
|
| [17] |
沈诞. 机器人辅助腹腔镜前列腺癌根治术治疗高危前列腺癌的研究[D]. 上海:第二军医大学,2012.
|
| [18] |
瞿旻,林恒之,王海峰,等. 机器人辅助腹腔镜下根治性前列腺切除术治疗高危前列腺癌400例报告[J]. 中华泌尿外科杂志,2017,38(6):424-427. DOI:10.3760/cma.j.issn.1000-6702.2017.06.007.
|
| [19] |
韩涛. 前列腺癌穿刺活检与根治切除病理的相关性研究[D]. 南京:南京大学,2013.
|
| [20] |
张铁龙. 前列腺癌患者临床资料库的建立及数据分析[D]. 上海:上海交通大学,2015.
|
| [21] |
丁攀. 前列腺癌根治术后切缘阳性的相关因素分析及风险预测[D]. 南昌:南昌大学,2019.
|
| [22] |
洪锴,马潞林,黄毅,等. 腹腔镜下前列腺癌根治术后切缘阳性的相关因素分析[J]. 中华泌尿外科杂志,2008,29(4):271-274. DOI:10.3321/j.issn:1000-6702.2008.04.015.
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
闫厚煜,邢金春,张开颜,等. 前列腺癌的早期诊断研究进展[J]. 临床泌尿外科杂志,2020,35(3):242-246. DOI:10.13201/j.issn.1001-1420.2020.03.018.
|
| [27] |
|
| [28] |
|
| [29] |
赫捷,陈万青,李霓,等. 中国前列腺癌筛查与早诊早治指南(2022,北京)[J]. 中华肿瘤杂志,2022,44(1):29-53. DOI:10.3760/cma.j.cn112152-20211226-00975.
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
宫正,李艺,刘重远,等. 骨盆径线及其他相关参数与前列腺癌根治术后尖部切缘阳性关系的探讨[J]. 现代肿瘤医学,2018,26(24):3973-3977.
|
| [36] |
梁迎春,许宁,吴宇鹏,等. 前列腺尖部形态对腹腔镜根治性前列腺切除术后尖部切缘阳性及生化复发的影响[J]. 中华外科杂志,2019,57(3):200-205. DOI:10.3760/cma.j.issn.0529-5815.2019.03.008.
|
| [1] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [2] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| [3] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [4] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [5] | LI Yutong, ZHAO Danting, JIANG Feng, WANG Yanna, LIU Yizong, LIANG Wenjuan, LU Jiahai. Systematic Review and Meta-analysis of the Efficacy and Safety of mRNA and Recombinant Protein Subunit Vaccines Against Respiratory Syncytial Virus [J]. Chinese General Practice, 2026, 29(19): 2744-2752. |
| [6] | ZHANG Wenbo, WANG Junlong, ZHANG Yuping, JIANG Shuai, WANG Huaqi. The Risk of Pre-COPD Populations Progressing to COPD under Different Criteria: a Meta-analysis [J]. Chinese General Practice, 2026, 29(19): 2735-2743. |
| [7] | ZHEN Rui, GU Xufang, GAO Shengwei, ZHANG Bowen, REN Zhenjuan, YANG Ruixuan. Burden of Cardiovascular Diseases Attributable to Metabolic Risk Factors in China 1990—2021 and Projected Trends from 2022 to 2035 [J]. Chinese General Practice, 2026, 29(15): 2077-2083. |
| [8] | TIAN Anni, YANG Jing, SUN Jing, WANG Shichun. Effect of Robot-assisted Training on the Recovery of Hand Motor Function in Patients with Different Stages of Stroke: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1911-1920. |
| [9] | ZHAN Li, HENG Zhaoyang, HE Liangyu, ZHAO Jie, CHEN Jie, XING Jinshan. Efficacy and Safety of CAR-T Therapy Targeting the B Cell Maturation Antigen on Relapsed/Refractory Multiple Myeloma in Chinese People: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1921-1930. |
| [10] | HU Jiaqi, LI Duan, FANG Hao, FAN Xingying, DU Wei, ZHOU Hanni. Study on Predictive Model of Non-genetic Risk Factors for Hyperuricemia in a Physical Examination Cohort [J]. Chinese General Practice, 2026, 29(10): 1324-1333. |
| [11] | WANG Fei, HAN Weiyu, SUN Tao. Moxibustion Combined with Three-step Therapy in the Treatment of Cancer Pain: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(09): 1203-1211. |
| [12] | PEI Zhiyi, ZHANG Xiaoxin, LIN Jiayi, ZHANG Xiangyi, KANG Xiaofeng. Systematic Review of the Quality and Application of Patient Decision Aids in Cardiovascular Disease Based on IPDAS 4.0 Criteria [J]. Chinese General Practice, 2026, 29(07): 945-952. |
| [13] | ZHANG Ling, HUANG Shuangying, XU Hui, MEI Huiting, HONG Yongping. Effects of Different Exercise Types on Fall Efficacy in the Elderly: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(06): 741-751. |
| [14] | LEI Yingying, ZHENG Siying, WANG Wenxin, JIANG Hong. Prevalence Trend and Prediction of Hypertensive Heart Disease in the World and China from 1990 to 2021 [J]. Chinese General Practice, 2026, 29(05): 641-648. |
| [15] | ZHAO Xuejiao, LI Juan, LI Yujie, LU Ting, Xian Lihong, YAN Huan. Prevalence Trends and Influencing Factors for Post-stroke Cognitive Impairment in China: a Meta-analysis [J]. Chinese General Practice, 2026, 29(03): 380-392. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||